Pancreatic Cancer Metastatic Clinical Trials

52 clinical trials for Pancreatic Cancer Metastatic across international registries, including 16 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma — RECRUITING · PHASE3
• Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 ) — RECRUITING · PHASE3
• Phase 2A Pilot C3 Trial of Recurrent/Refractory Metastatic Advanced Pancreatic Cancer — RECRUITING · PHASE1
• Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma — RECRUITING · PHASE3
• Holistic Acupuncture for Patients With Chemotherapy Induced Nausea — RECRUITING · NA
• A Phase Ib/II Clinical Study of Regorafenib Combined With Toripalimab and Albumin-bound Paclitaxel for the Third-line Treatment of Advanced Pancreatic Cancer — RECRUITING · PHASE1
• Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients — RECRUITING · PHASE1
• PhIbRandomGemcitabine(G)w/or w/Out Pitavastatin(P)MainTx UnresecPancreaticAdenocarcinoma(uPDAC) — RECRUITING · PHASE1
• A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer — RECRUITING · PHASE1
• EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors — RECRUITING · PHASE1
• Polymeric Micellar Paclitaxel for Metastatic Pancreatic Cancer — RECRUITING · PHASE3
• A Single-center, Prospective, Two Cohort Study of Surufatinib Combined With AG or AG in the First-line Treatment of Locally Advanced or Metastatic Pancreatic Cancer — RECRUITING · PHASE2
• Medical Cannabis in Patients With Advanced Pancreatic and Colorectal Cancer — RECRUITING · PHASE2
• Clinical Study of Carbon Ion Radiotherapy for Pancreatic Cancer. — RECRUITING · NA
• Conversion Surgery Vs. Palliative Care in Pancreatic Cancer Oligometastatic to the Liver — RECRUITING · PHASE2
• Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer — RECRUITING · PHASE2
• Vilastobart+Retifanlimab in BRCA or PALB2 Deficient PC — NOT_YET_RECRUITING · PHASE2
• Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic Pancreatic Adenocarcinoma — OTHER
• A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Study on the Construction and Application of a Large Model Corpus for Pancreatic Cancer Based on Real Clinical Cases — NOT_YET_RECRUITING
• The Seven Trial: Exploiting the Unfolded Protein Response — TERMINATED · PHASE1
• Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications — TERMINATED · PHASE1
• A Study in Advanced or Metastatic Gastrointestinal Cancers Exploring Treatment Combinations With Pelareorep and Atezolizumab — ACTIVE_NOT_RECRUITING · PHASE1
• MT-601 Administered To Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer — NOT_YET_RECRUITING · PHASE1
• A Study of Narmafotinib Given in Combination With Modified FOLFIRINOX in Patients With Metastatic Pancreatic Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC) — ACTIVE_NOT_RECRUITING · PHASE1
• Pancreatic Adenocarcinoma Signature Stratification for Treatment — COMPLETED · PHASE2
• Predictive Value of Transcriptome-based OncoTreat/Oncotarget and Organoid Testing in Metastatic Pancreatic Cancer. — NOT_YET_RECRUITING
• Phase Ib/II Study to Evaluate the Safety and Efficacy of IBI363 in Combination With Chemotherapy as Second-Line Therapy for Unresectable Locally Advanced or Metastatic Pancreatic Cancer — NOT_YET_RECRUITING · PHASE1
• Adebrelimab Infusion Plus Standard Care for Pancreatic Cancer With Pleural or Peritoneal Effusions — NOT_YET_RECRUITING · PHASE2
• A Clinical Study Evaluating the Safety, Tolerability, Preliminary Efficacy and Immunogenicity of a Tumor Vaccine Injection Targeting Stressinducible Proteins MICA/B in Combination With the AG Regimen in Patients With Metastatic Pancreatic Cancer — NOT_YET_RECRUITING · PHASE1
• Safety Study of Whole Body Hyperthermia for Advanced Cancer — COMPLETED · NA
• INCMGA00012 in Patients With Previously Treated Unresectable or Metastatic Adenosquamous Pancreatic or Ampullary Cancer — COMPLETED · PHASE2
• Influence of Metastatic Sites on Survival Outcomes and Predictive Factors for Extended Survival in Metastatic Pancreatic Cancer a Retrospective Study — NOT_YET_RECRUITING
• SENECA: First Line metaStatic pancrEatic caNcer Primary and Distant (if Oligometastatic) lEsion direCted rAdiotherapy — ACTIVE_NOT_RECRUITING · PHASE3
• Does Recurrent Pancreatic Cancer Really Have Similar Outcome Compared With Primary Metastatic Pancreatic Cancer? — COMPLETED
• Efficacy and Safety of Dronabinol in the Improvement of Chemotherapy-induced and Tumor-related Symptoms in Advanced Pancreatic Cancer — COMPLETED · PHASE3
• Adebrelimab Combined With AG Regimen in Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer — NOT_YET_RECRUITING · PHASE2
• Personalized Tumor Neoantigen MRNA Therapy for Advanced Pancreatic Cancer. — NOT_YET_RECRUITING · PHASE1
• RWE on Patients With mPDAC Long-term Survival After Treatment With Liposomal Irinotecan — OTHER
• A Prospective, Randomized, Double-blinded, Multi-center Clinical Trial to Evaluate the Efficiency and Safety of Anti-PD1 Antibody (Camrelizumab) Combined With Paclitaxel(Albumin Bound) and Gemcitabine as First-line Therapy in Patients With Metastatic Pancreatic Cancer — OTHER · PHASE3
• RP72 Monotherapy and in Combination With Gemcitabine in Patients With Pancreatic Cancer — OTHER · PHASE1
• Ipilimumab, Maraviroc and Nivolumab in Advanced Metastatic Colorectal and Pancreatic Cancer the LUMINESCENCE Trial — COMPLETED · PHASE1
• Neoantigen-Targeted Vaccine Combined With Anti-PD-1 Antibody for Patients With Stage IV MMR-p Colon and Pancreatic Ductal Cancer — WITHDRAWN · PHASE1
• PanDox: Targeted Doxorubicin in Pancreatic Tumours — WITHDRAWN · PHASE1
• Study Evaluating Efficacy and Safety of FFX Versus Combination of CPI-613 With mFFX in Patients With Metastatic Adenocarcinoma of the Pancreas — COMPLETED · PHASE3
• Study of SBP-101 Combined With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer — COMPLETED · PHASE1
• Telemedicine in the Management of Pain in Patients With Advanced or Metastatic Pancreatic Cancer — OTHER · NA
• Study of Irinotecan Liposome Injection-containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma — OTHER · PHASE2
• Phase II Study of 5-FU, Oxaliplatin Plus Dasatinib in Metastatic Pancreatic Adenocarcinoma — COMPLETED · PHASE2

Refine this search